1. Home
  2. FRA vs CYRX Comparison

FRA vs CYRX Comparison

Compare FRA & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock Floating Rate Income Strategies Fund Inc

FRA

Blackrock Floating Rate Income Strategies Fund Inc

HOLD

Current Price

$11.06

Market Cap

415.1M

Sector

Finance

ML Signal

HOLD

Logo CryoPort Inc.

CYRX

CryoPort Inc.

HOLD

Current Price

$8.10

Market Cap

421.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRA
CYRX
Founded
2003
1999
Country
United States
United States
Employees
N/A
1100
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
415.1M
421.6M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
FRA
CYRX
Price
$11.06
$8.10
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$12.94
AVG Volume (30 Days)
174.0K
341.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
11.06%
N/A
EPS Growth
N/A
156.22
EPS
N/A
1.40
Revenue
N/A
$176,177,000.00
Revenue This Year
N/A
$9.71
Revenue Next Year
N/A
$9.56
P/E Ratio
N/A
$4.99
Revenue Growth
N/A
N/A
52 Week Low
$10.90
$4.63
52 Week High
$13.41
$11.45

Technical Indicators

Market Signals
Indicator
FRA
CYRX
Relative Strength Index (RSI) 26.15 37.26
Support Level N/A $6.57
Resistance Level $11.80 $8.45
Average True Range (ATR) 0.11 0.51
MACD -0.02 0.04
Stochastic Oscillator 2.26 25.71

Price Performance

Historical Comparison
FRA
CYRX

About FRA Blackrock Floating Rate Income Strategies Fund Inc

Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.

About CYRX CryoPort Inc.

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Share on Social Networks: